...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
IDXX NASDAQ 🇺🇸 US
IDEXX Laboratories
Healthcare
Watch
Price Zone: Buy Zone
🔒 Full AI Analysis — Pro
49Score
DipBuster Score™
$567.84 +$8.77 (+1.57%) Live price · Source: Yahoo
52-Week Position
$518.55 20% of range $769.98
Dividend
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$769.98
52W Low$518.55
DipBuster Brief Key signals at a glance
Zone: Buy Zone
Bullish
Near 52-Week Low — Wide Margin of Safety
At 20% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio
Mkt CapN/A
52W Position20% of range
EV/EBITDA
Cash Flow
FCF Yield
FCF / Share
Op. Cash Flow
Margins
Gross Margin
Op. Margin
Net Margin
Balance Sheet
Cash
Total Debt
Net Cash
Dividend
Yield
Annual / shNone
Beta
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at IDEXX Laboratories (IDXX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-06-01 Fennell George SELL 639
2026-06-01 Fennell George SELL 284
2026-06-01 Fennell George BUY 639
2026-05-12 Peacock Karen BUY 234
2026-05-12 Peacock Karen BUY 525
2026-05-12 Samad Sam BUY 234
2026-05-12 Samad Sam BUY 525
2026-05-12 Britt Irene Chang BUY 234
2026-05-12 Britt Irene Chang BUY 525
2026-05-12 Vandebroek Sophie V. BUY 234

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$769.98
52W Low$518.55

52-Week Range

$518.55Now$769.98
20% through annual range
From 52W High−26.3%
From 52W Low+9.5%
📖 Plain English Summary
IDEXX Laboratories is at 20% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for IDXX 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — IDXX
Heuristic · balance sheet, insider filings, price data, academic research

IDEXX Laboratories — DipBuster Score 49/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track IDEXX Laboratories free

Add IDXX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Get Started Free →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 32/25
Momentum & Volume 12/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
11 /100 · NEUTRAL
dip depth 11/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 49/100
📊 Run a full check in the AI analysis tab for a deeper look.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →